P2Y12受体在癌症发展中的作用和最近的进展
Yanni Xi1,2,3, Zhenya Min2,3, Mianxue Liu2,3
1Department of General Surgery, Jiujiang Hospital of Traditional Chinese Medicine, Jiujiang, Jiangxi, 332007, People's Republic of China.
Purinergic signalling
|June 14, 2024
概括
P2Y12受体 (P2Y12R) 在癌症进展中发挥作用,可能是治疗点. 然而,长期使用P2Y12R抑制剂可能会增加癌症风险,需要进一步调查.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- P2Y12受体 (P2Y12R) 是一种由腺激活的G蛋白结合受体,对于血小板功能,血液静止和血栓形成至关重要.
- P2Y12R激活通过促进血小板与癌细胞的聚合,瘤血管生成以及影响瘤免疫微环境 (TIME) 和耐药性来影响癌症的进展.
研究的目的:
- 审查P2Y12R的结构和功能特征及其在癌症发展和转移中的多方面的作用.
- 探索P2Y12R抑制剂作为各种癌症治疗策略的潜力.
- 总结有关瘤学中P2Y12R抑制剂的基础和临床研究的最新进展.
主要方法:
- 基础和临床研究的文献综述.
- 分析P2Y12R的结构和功能.
- 在不同类型的瘤中研究P2Y12R抑制剂的疗效.
主要成果:
- P2Y12R信号与促进癌症进展有关,这表明P2Y12R是潜在的治疗标.
- 在各种研究中,P2Y12R抑制剂在抑制癌症进展方面表现出有效性.
- 新出现的证据表明,长期使用P2Y12R抑制剂与癌症风险增加之间存在潜在联系,需要进一步的机制性探索.
结论:
- P2Y12R是癌症生物学中的一个重要因素,抑制剂显示出癌症治疗的前景.
- P2Y12R的双重作用,可能促进癌症,而其抑制剂提供治疗益处,需要仔细考虑.
- 需要进一步的研究,以阐明与长期使用P2Y12R抑制剂相关的潜在癌症风险增加背后的机制.
相关概念视频
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
517
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
517
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K